Larson Financial Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.38K Buy
288
+146
+103% +$3.87K ﹤0.01% 2595
2026
Q2
$2.55K Sell
142
-59
-29% -$912 ﹤0.01% 3043
2026
Q1
$2.79K Buy
201
+160
+390% +$2.25K ﹤0.01% 2860
2025
Q4
$495 Buy
+41
New +$557 ﹤0.01% 3126

Other funds holding AMLX

Larson Financial Group's AMLX Position: Q3 2026 in Review

Larson Financial Group increased its Amylyx Pharmaceuticals (AMLX) stake by 103% in Q3 2026, buying an estimated $3.87K and bringing the position to 288 shares worth $8.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

Larson Financial Group first reported a position in AMLX in Q4 2025 and has held it in 4 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • Larson Financial Group held 288 shares of Amylyx Pharmaceuticals worth $8.38K as of Q3 2026.
  • Larson Financial Group bought 146 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $3.87K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2595 holding.
  • Larson Financial Group first reported a position in Amylyx Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.